85 related articles for article (PubMed ID: 16121403)
1. Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.
Juhasz F; Kozma L; Stenszky V; Gyory F; Luckas G; Farid NR
Cancer; 2005 Oct; 104(8):1603-8. PubMed ID: 16121403
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.
Porto T; Coelho I; Boavida J; Pereira C; Nunes JM; Mendonça D; Martins B; Sobrinho LG; Leite V
Clin Endocrinol (Oxf); 2006 Feb; 64(2):179-83. PubMed ID: 16430717
[TBL] [Abstract][Full Text] [Related]
3. Frequency of HLA-C alleles in differentiated thyroid carcinoma in southeastern Spain.
Ríos A; Rodríguez JM; Moya MR; Galindo PJ; Canteras M; Alvarez MR; Parrilla P
Cancer; 2004 Jan; 100(2):264-9. PubMed ID: 14716759
[TBL] [Abstract][Full Text] [Related]
4. Associations between HLA-C alleles and papillary thyroid carcinoma.
Haghpanah V; Khalooghi K; Adabi K; Amiri P; Tavangar SM; Amirzargar A; Ghaffari H; Yazdani N; Nikbin B; Larijani B; Amoli MM
Cancer Biomark; 2009; 5(1):19-22. PubMed ID: 19242058
[TBL] [Abstract][Full Text] [Related]
5. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
6. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
7. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
[TBL] [Abstract][Full Text] [Related]
8. Weak or absent evidence for the association of HLA-DR antigens with risk of thyroid carcinoma: a meta-analysis of observational studies.
Kamdi AS; Kandavalli NB; Emusu D; Jain N; Mamtani M; Porterfield JR
Tissue Antigens; 2011 Nov; 78(5):382-9. PubMed ID: 21812765
[TBL] [Abstract][Full Text] [Related]
9. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
11. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
12. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
13. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
15. Immunogenetic and immunologic studies of differentiated thyroid cancer.
Juhasz F; Boros P; Szegedi G; Balazs G; Suranyi P; Kraszits E; Stenszky V; Farid NR
Cancer; 1989 Apr; 63(7):1318-26. PubMed ID: 2784072
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
18. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
19. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
20. Strong association between an HLA-DR antigen and thyroid carcinoma.
Panza N; Del Vecchio L; Maio M; De Felice M; Lombardi G; Minozzi M; Zappacosta S
Tissue Antigens; 1982 Aug; 20(2):155-8. PubMed ID: 6814009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
